President
&
Chief Executive Officer,
Founder


Tsukasa Sugo, Ph.D.

Tsukasa Sugo received B.S. in Chemistry from the University of Tokyo and Ph.D. degrees from Graduate School of Pharmaceutical Sciences, the University of Tokyo. After the researches in the Institute of Medical Science, the University of Tokyo, he worked at Takeda Pharmaceutical Company Limited for 25 years in G protein-coupled receptor research, nucleic acid pharmaceutical research and genome editing research. During his career in Takeda, he had an opportunity to work for Alnylam Pharmaceuticals as a visiting scientist. He was awarded as the Outstanding Reviewers status for Journal of Controlled Release.
Vise President
&
Chief Operating Officer,
Co-Founder

Mie Yoshimatsu

Mie Yoshimatsu graduated from Kyoto Pharmaceutical University with a Bachelor of Pharmacy degree. She joined Takeda Pharmaceutical Company Limited and was in charge of a wide range of tasks including monoclonal antibody production, medical pharmacology (in vitro, in vivo), screening and molecular biology. She has track record of INDs including Relugolix, Resatorvid, etc.
Director

Akihiro Tomoyasu, Ph.D.

Akihiro Tomoyasu received M.S. in Pharmaceutical Sciences from Hokkaido University. He joined Snow Brand Milk Industry Company, Limited. (currently MEGMILK SNOW BRAND Co.,Ltd.) and then joined Chugai Pharmaceutical Co., Ltd. After the work in life sciences industry, he was engaged in venture investment development business in UFJ Capital Co., Ltd. (currently Mitsubishi UFJ Capital Co., Ltd.). He is currently the external directors of KinoPharma, Inc., Kringle Pharma, Inc., and the director of Anicom Capital Co. Ltd. since 2016.
Auditor

Kazunari Toda,
Attorney at Law

Kazunari Toda graduated from the Faculty of Law, Seijo University and completed a Master’s degree in law at Waseda University. He registered as a qualified attorney in 2010. After passing the Japan Patent Office and a company listed with first section of the TSE, he joined GVA Law Office (partner). He is currently the outside auditor of Prime Strategy Co., Ltd., and the outside director of Integrative Medical & Preventive Medical Network.